The Plasma Proteome: High Abundance versus Low Abundance - January 10-11, 2006, San Diego, CA, USA

Expert Review of Proteomics

Volumn 3, Issue 2, 2006, Pages 175-178

  Zhang, Hui ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

CONFERENCE PAPER; DRUG SCREENING; PROTEIN ANALYSIS; REPRODUCIBILITY; UNITED STATES;

BLOOD PROTEINS; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 33745603972     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.3.2.175     Document Type: Conference Paper

References (13)

1. Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5, 3226-3245 (2005).
2. States DJ, Omenn GS, Blackwell TW et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nature Biotechnol. 24, 333-338 (2006).
3. Pieper R, Su Q, Gatlin CL, Huang ST, Anderson NL, Steiner S. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3, 422-432 (2003).
4. Zhang H, Yan W, Aebersold R. Chemical probes and tandem mass spectrometry: a strategy for the quantitative analysis of proteomes and subproteomes. Curr. Opin. Chem. Biol. 8, 66-75 (2004).
5. Anderson NL Hunter CL. Quantitative mass spectrometric MRM assays for major plasma proteins. Mol. Cell. Proteomics (2006) (In Press).
6. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 3, 235-244 (2004).
7. Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nature Biotechnol. 21, 660-666 (2003).
8. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nature Rev. Cancer 5, 845-856 (2005).
9. Zhang H, Yi EC, Li XJ et al. High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell. Proteomics 4, 144-155 (2005).
10. Pan S, Zhang H, Rush J et al. High throughput proteome screening for biomarker detection. Mol. Cell. Proteomics 4, 182-190 (2005).
11. Wang W, Zhou H, Lin H et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 75, 4818-4826 (2003).
12. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867 (2002).
13. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Investigating diversity in human plasma proteins. Proc. Natl Acad. Sci. USA 102, 10852-10857 (2005).